Newsroom

Displaying 1–10 of 124

May 13, 2026

Seer Files Patent Infringement Lawsuit Against Nanomics

May 4, 2026

Seer Announces Appointment of Anthony Bazarko as Chief Commercial Officer

April 29, 2026

Seer to Report First Quarter 2026 Financial Results on May 13, 2026

April 27, 2026

Seer Board of Directors Unanimously Rejects Revised Unsolicited Proposal from Radoff-JEC Group

April 13, 2026

Seer Confirms Receipt of Unsolicited Proposal and Director Candidate Nominations from Radoff-JEC Group

April 9, 2026

Seer and Precision Health Research, Singapore Sign Collaboration to Provide Deep, Unbiased Proteomics on 10,000 PRECISE SG100K Samples

March 30, 2026

Patent Board Upholds Seer's Nano and Micro Particle Protein Enrichment Patent in a Challenge by Bruker Subsidiaries

February 26, 2026

Seer Adopts Limited Duration Tax Benefit Preservation Plan to Protect its Valuable Tax Assets

February 26, 2026

Seer Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Full Year 2026 Outlook

February 19, 2026

Leading Scientists Demonstrate How Seer’s Proteograph Product Suite Advances Cardiovascular and Neurodegenerative Research at US HUPO 2026

Starting your proteomics research is effortless

Connect with an expert to discuss which path to the full proteome is right for you.

  1. Bring the Proteograph Product Suite in-house
  2. Run a project with
    Seer Technology
    Access Center
  3. Conduct a project with
    a Seer service provider
    or Center of Excellence